Literature DB >> 29474962

In vitro and in vivo delivery of siRNA via VIPER polymer system to lung cells.

Daniel P Feldmann1, Yilong Cheng2, Rima Kandil3, Yuran Xie4, Mariam Mohammadi3, Hartmann Harz5, Akhil Sharma4, David J Peeler2, Anna Moszczynska4, Heinrich Leonhardt5, Suzie H Pun2, Olivia M Merkel6.   

Abstract

The block copolymer VIPER (virus-inspired polymer for endosomal release) has been reported to be a promising novel delivery system of DNA plasmids both in vitro and in vivo. VIPER is comprised of a polycation segment for condensation of nucleic acids as well as a pH-sensitive segment that exposes the membrane lytic peptide melittin in acidic environments to facilitate endosomal escape. The objective of this study was to investigate VIPER/siRNA polyplex characteristics, and compare their in vitro and in vivo performance with commercially available transfection reagents and a control version of VIPER lacking melittin. VIPER/siRNA polyplexes were formulated and characterized at various charge ratios and shown to be efficiently internalized in cultured cells. Target mRNA knockdown was confirmed by both flow cytometry and qRT-PCR and the kinetics of knockdown was monitored by live cell spinning disk microscopy, revealing knockdown starting by 4 h post-delivery. Intratracheal instillation of VIPER particles formulated with sequence specific siRNA to the lung of mice resulted in a significantly more efficient knockdown of GAPDH compared to treatment with VIPER particles formulated with scrambled sequence siRNA. We also demonstrated using pH-sensitive labels that VIPER particles experience less acidic environments compared to control polyplexes. In summary, VIPER/siRNA polyplexes efficiently deliver siRNA in vivo resulting in robust gene silencing (>75% knockdown) within the lung.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endosomal escape; Melittin; Pulmonary delivery; pH-sensitive polymer; siRNA delivery

Mesh:

Substances:

Year:  2018        PMID: 29474962      PMCID: PMC6031299          DOI: 10.1016/j.jconrel.2018.02.017

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  33 in total

Review 1.  Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers.

Authors:  Claudia Scholz; Ernst Wagner
Journal:  J Control Release       Date:  2011-11-23       Impact factor: 9.776

2.  Nanoparticle-mediated cellular response is size-dependent.

Authors:  Wen Jiang; Betty Y S Kim; James T Rutka; Warren C W Chan
Journal:  Nat Nanotechnol       Date:  2008-03-02       Impact factor: 39.213

Review 3.  Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond).

Authors:  Ulrich Lächelt; Ernst Wagner
Journal:  Chem Rev       Date:  2015-04-15       Impact factor: 60.622

4.  Revisiting the value of competition assays in folate receptor-mediated drug delivery.

Authors:  Steven K Jones; Anwesha Sarkar; Daniel P Feldmann; Peter Hoffmann; Olivia M Merkel
Journal:  Biomaterials       Date:  2017-05-22       Impact factor: 12.479

Review 5.  Genetic pharmacology: progresses in siRNA delivery and therapeutic applications.

Authors:  D Scherman; A Rousseau; P Bigey; V Escriou
Journal:  Gene Ther       Date:  2017-01-25       Impact factor: 5.250

6.  Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.

Authors:  G Thurston; J W McLean; M Rizen; P Baluk; A Haskell; T J Murphy; D Hanahan; D M McDonald
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

7.  Amphiphilic biodegradable PEG-PCL-PEI triblock copolymers for FRET-capable in vitro and in vivo delivery of siRNA and quantum dots.

Authors:  Thomas Endres; Mengyao Zheng; Ayşe Kılıç; Agnieszka Turowska; Moritz Beck-Broichsitter; Harald Renz; Olivia M Merkel; Thomas Kissel
Journal:  Mol Pharm       Date:  2014-03-12       Impact factor: 4.939

8.  Melittin-grafted HPMA-oligolysine based copolymers for gene delivery.

Authors:  Joan G Schellinger; Joshuel A Pahang; Russell N Johnson; David S H Chu; Drew L Sellers; Don O Maris; Anthony J Convertine; Patrick S Stayton; Philip J Horner; Suzie H Pun
Journal:  Biomaterials       Date:  2012-12-20       Impact factor: 12.479

9.  A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals.

Authors:  Yiguang Wang; Kejin Zhou; Gang Huang; Christopher Hensley; Xiaonan Huang; Xinpeng Ma; Tian Zhao; Baran D Sumer; Ralph J DeBerardinis; Jinming Gao
Journal:  Nat Mater       Date:  2013-12-08       Impact factor: 43.841

10.  Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma.

Authors:  Yuran Xie; Na Hyung Kim; Venkatareddy Nadithe; Dana Schalk; Archana Thakur; Ayşe Kılıç; Lawrence G Lum; David J P Bassett; Olivia M Merkel
Journal:  J Control Release       Date:  2016-03-19       Impact factor: 9.776

View more
  13 in total

1.  Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles.

Authors:  Aditi Mehta; Elena Dalle Vedove; Lorenz Isert; Olivia M Merkel
Journal:  Pharm Res       Date:  2019-07-09       Impact factor: 4.200

2.  Identifying key barriers in cationic polymer gene delivery to human T cells.

Authors:  Brynn R Olden; Emmeline Cheng; Yilong Cheng; Suzie H Pun
Journal:  Biomater Sci       Date:  2019-02-26       Impact factor: 6.843

Review 3.  Endosomal Escape of Bioactives Deployed via Nanocarriers: Insights Into the Design of Polymeric Micelles.

Authors:  Adeel Masood Butt; Nabiha Abdullah; Nur Najihah Izzati Mat Rani; Naveed Ahmad; Mohd Cairul Iqbal Mohd Amin
Journal:  Pharm Res       Date:  2022-05-26       Impact factor: 4.200

Review 4.  T-cell targeted pulmonary siRNA delivery for the treatment of asthma.

Authors:  Tobias W M Keil; Domizia Baldassi; Olivia M Merkel
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-08

Review 5.  Current role of nanoparticles in the treatment of lung cancer.

Authors:  Eliseo Carrasco-Esteban; José Antonio Domínguez-Rullán; Patricia Barrionuevo-Castillo; Lira Pelari-Mici; Olwen Leaman; Sara Sastre-Gallego; Fernando López-Campos
Journal:  J Clin Transl Res       Date:  2021-03-16

6.  Can pulmonary RNA delivery improve our pandemic preparedness?

Authors:  Olivia M Merkel
Journal:  J Control Release       Date:  2022-03-28       Impact factor: 11.467

Review 7.  siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies?

Authors:  Aditi Mehta; Thomas Michler; Olivia M Merkel
Journal:  Adv Healthc Mater       Date:  2021-01-27       Impact factor: 11.092

Review 8.  Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers.

Authors:  Mikhail Durymanov; Joshua Reineke
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

Review 9.  Inhaled RNA Therapy: From Promise to Reality.

Authors:  Michael Y T Chow; Yingshan Qiu; Jenny K W Lam
Journal:  Trends Pharmacol Sci       Date:  2020-09-04       Impact factor: 14.819

Review 10.  Melittin-Based Nano-Delivery Systems for Cancer Therapy.

Authors:  Anqi Wang; Yuan Zheng; Wanxin Zhu; Liuxin Yang; Yang Yang; Jinliang Peng
Journal:  Biomolecules       Date:  2022-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.